 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price(s) |
Delete |
D648552 |
 |
(2R)-2-{[(tert-butoxy)carbonyl]amino}-2-(oxetan-3-yl)acetic acid |
97%
|
$225/100mg, $285/250MG, $480/500MG, $600/1G |
 |
D696935 |
 |
(R)-2-(2-Pyrrolidinyl)acetic Acid |
>95%
|
$330/5g |
 |
Y3253189 |
 |
(thiolan-3-ylmethyl)hydrazine dihydrochloride |
95%
|
$455/50mg, $665/100mg, $940/250mg, $1480/500mg, $1895/1g, $3710/2.5g, $5485/5g |
 |
Y3224025 |
 |
[(3,4-dimethylphenyl)methyl](methyl)amine hydrochloride |
95%
|
$85/100mg, $100/250mg, $120/500mg, $140/1g |
 |
Y3179437 |
 |
1-(3-amino-2-hydroxypropyl)pyrrolidin-2-one |
95%
|
$170/50mg, $240/100mg, $325/250mg, $580/500mg, $775/1g, $1510/2.5g |
 |
D774111 |
 |
1-fluoro-3-(methylsulfanylmethyl)benzene |
95%
|
$180/100mg, $255/250mg, $335/500mg, $475/1g, $815/2g, $1395/5g |
 |
Y1124704 |
 |
1-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-1H-isoindole |
95%
|
$1115/500mg, $1765/1g, $6585/5g |
 |
Y3140799 |
 |
3-(METHOXYMETHYL)-1,2,4-OXADIAZOL-5-AMINE |
95%
|
$285/50mg, $415/100mg, $575/250mg, $905/500mg, $1160/1g |
 |
Y0976197 |
 |
3-bromo-N1-methylbenzene-1,2-diamine |
95%
|
$480/1g |
 |
Y3105441 |
 |
4-tert-butylpiperidin-1-amine dihydrochloride |
95%
|
$310/50mg, $455/100mg, $635/250mg, $995/500mg, $1270/1g, $2490/2.5g, $3680/5g |
 |
D618758 |
 |
6-Hydroxypurine |
97%
|
$220/500g, $320/1kg |
 |
Y1481268 |
 |
7-bromo-3-(2,6-dibenzyloxy-3-pyridyl)-1-methyl-indazole |
97%
|
$105/250MG, $150/500MG, $220/1G, $640/5G, $1070/10G, $2145/25G, $3435/50G |
 |
Y1240947 |
 |
L-Threonine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl- |
98% (NMR)
|
$310/250mg, $520/1g, $1645/5g, $5945/25g |
 |
Y3293775 |
 |
methyl2-(aminomethyl)oxolane-2-carboxylatehydrochloride |
95%
|
$365/50mg, $530/100mg, $760/250mg, $1190/500mg, $1530/1g |
 |
D683712 |
 |
N-HYDROXY-5-CHLORO-1H-INDOLE-3-CARBOXAMIDINE |
95%
|
|
 |
Y3188835 |
 |
rac-methyl (2aR,7bR)-1H,2H,2aH,3H,7bH-cyclobuta[b]indole-2a-carboxylate hydrochloride |
95%
|
$470/50mg, $685/100mg, $975/250mg, $1535/500mg, $1965/1g |
 |
|
|
|
 |
 |
 |